Array hires Howard Holden as VP
This article was originally published in Scrip
Executive Summary
Array BioPharma, a company focused on discovering and developing targeted small-molecule drugs to treat cancer and inflammatory diseases has appointed Dr Howard Holden vice-president of regulatory affairs and quality assurance. Dr Holden served as senior vice-president of regulatory affairs and compliance at Nereus Pharmaceuticals from 2005-2012.